Additional file 1: Figure S1. An overview of the CORDIALLY study. Figure S2. Patient disposition. Figure S3. (A) T2D study medication prescriptions by country, (B) patient enrolment by country and by HCP specialty (Prescribed Patient Set). Table S1. CORDIALLY study outcomes
Detailed description of the patientsâ questionnaire. A comprehensive description of the patientsâ...
Names of Ethics Review Boards granting approval to MOSAIc, by country. (DOCX 23Â kb
Additional file 1: Table S1. Baseline characteristics of the subgroup of study participants fully ch...
AGREEMENT Investigators. Table S1. Stratification of patients according to sites capacity, treatment...
Table S1. Summary of trials integrated for meta-analysis. Overview of the design of each trial used ...
Baseline characteristics of patients with T2DM with baseline and follow-up A1C measurements treated ...
Medication adherence among patients with type 2 diabetes mellitus of Anuradhapura, Sri Lanka, 2017. ...
Map of the study area (Figure S1); review of reference guidelines on diabetes management available i...
Table S2. Outcomes of responders and nonresponders to IGlar at 24 weeks by study. Data are HbA1c, in...
Excess risk of disease for selected concomitant co-morbidities (2007â2010). The table shows the pr...
DATES analysis plan 2018-07-11. Analysis plan of âDiabetes and Text Messaging Study to support sel...
Background/Aims: The prevalence of diabetes mellitus type 2 and kidney disease in these patients var...
Additional file 1: Table S1. Descriptive statistics for each drug and dose amount at index date in e...
Baseline Characteristics of Respondents and Non-respondents, Tehran Lipid and Glucose Study (1999â...
Table S1. Type 2 diabetes prevalence by age group. Navarre (Spain), 2014 (DOCX 12 kb
Detailed description of the patientsâ questionnaire. A comprehensive description of the patientsâ...
Names of Ethics Review Boards granting approval to MOSAIc, by country. (DOCX 23Â kb
Additional file 1: Table S1. Baseline characteristics of the subgroup of study participants fully ch...
AGREEMENT Investigators. Table S1. Stratification of patients according to sites capacity, treatment...
Table S1. Summary of trials integrated for meta-analysis. Overview of the design of each trial used ...
Baseline characteristics of patients with T2DM with baseline and follow-up A1C measurements treated ...
Medication adherence among patients with type 2 diabetes mellitus of Anuradhapura, Sri Lanka, 2017. ...
Map of the study area (Figure S1); review of reference guidelines on diabetes management available i...
Table S2. Outcomes of responders and nonresponders to IGlar at 24 weeks by study. Data are HbA1c, in...
Excess risk of disease for selected concomitant co-morbidities (2007â2010). The table shows the pr...
DATES analysis plan 2018-07-11. Analysis plan of âDiabetes and Text Messaging Study to support sel...
Background/Aims: The prevalence of diabetes mellitus type 2 and kidney disease in these patients var...
Additional file 1: Table S1. Descriptive statistics for each drug and dose amount at index date in e...
Baseline Characteristics of Respondents and Non-respondents, Tehran Lipid and Glucose Study (1999â...
Table S1. Type 2 diabetes prevalence by age group. Navarre (Spain), 2014 (DOCX 12 kb
Detailed description of the patientsâ questionnaire. A comprehensive description of the patientsâ...
Names of Ethics Review Boards granting approval to MOSAIc, by country. (DOCX 23Â kb
Additional file 1: Table S1. Baseline characteristics of the subgroup of study participants fully ch...